Detalhe da pesquisa
1.
Efficient chimeric antigen receptor targeting of a central epitope of CD22.
J Biol Chem
; 299(7): 104883, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37269947
2.
New CEACAM-targeting 2A3 single-domain antibody-based chimeric antigen receptor T-cells produce anticancer effects in vitro and in vivo.
Cancer Immunol Immunother
; 73(2): 30, 2024 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38279989
3.
Asciminib stands out as the superior tyrosine kinase inhibitor to combine with anti-CD20 monoclonal antibodies for the treatment of CD20+ Philadelphia-positive B-cell precursor acute lymphoblastic leukemia in preclinical models.
Haematologica
; 2024 Jun 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38841802
4.
Molecular Aspects of Resistance to Immunotherapies-Advances in Understanding and Management of Diffuse Large B-Cell Lymphoma.
Int J Mol Sci
; 23(3)2022 Jan 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35163421
5.
CD37 in B Cell Derived Tumors-More than Just a Docking Point for Monoclonal Antibodies.
Int J Mol Sci
; 21(24)2020 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33333768
6.
HDAC6 inhibition upregulates CD20 levels and increases the efficacy of anti-CD20 monoclonal antibodies.
Blood
; 130(14): 1628-1638, 2017 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28830887
7.
Adenanthin, a new inhibitor of thiol-dependent antioxidant enzymes, impairs the effector functions of human natural killer cells.
Immunology
; 146(1): 173-83, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26094816
8.
B-cell receptor signaling in the pathogenesis of lymphoid malignancies.
Blood Cells Mol Dis
; 55(3): 255-65, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26227856
9.
Concomitant inhibition of the thioredoxin system and nonhomologous DNA repair potently sensitizes Philadelphia-positive lymphoid leukemia to tyrosine kinase inhibitors.
Hemasphere
; 8(3): e56, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38486859
10.
CD20 expression regulates CD37 levels in B-cell lymphoma - implications for immunotherapies.
Oncoimmunology
; 13(1): 2362454, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38846084
11.
Prenyltransferases regulate CD20 protein levels and influence anti-CD20 monoclonal antibody-mediated activation of complement-dependent cytotoxicity.
J Biol Chem
; 287(38): 31983-93, 2012 Sep 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-22843692
12.
Bortezomib modulates surface CD20 in B-cell malignancies and affects rituximab-mediated complement-dependent cytotoxicity.
Blood
; 115(18): 3745-55, 2010 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-20200358
13.
Immune Evasion as the Main Challenge for Immunotherapy of Cancer.
Cancers (Basel)
; 14(15)2022 Jul 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35892880
14.
In Vitro Diffuse Large B-Cell Lymphoma Cell Line Models as Tools to Investigate Novel Immunotherapeutic Strategies.
Cancers (Basel)
; 15(1)2022 Dec 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36612228
15.
PD-L1 CAR effector cells induce self-amplifying cytotoxic effects against target cells.
J Immunother Cancer
; 10(1)2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35078921
16.
Potent, p53-independent induction of NOXA sensitizes MLL-rearranged B-cell acute lymphoblastic leukemia cells to venetoclax.
Oncogene
; 41(11): 1600-1609, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35091682
17.
PRDX-1 Supports the Survival and Antitumor Activity of Primary and CAR-Modified NK Cells under Oxidative Stress.
Cancer Immunol Res
; 10(2): 228-244, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34853030
18.
Cardiotoxicity of the anticancer therapeutic agent bortezomib.
Am J Pathol
; 176(6): 2658-68, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20519734
19.
The "Magic Bullet" Is Here? Cell-Based Immunotherapies for Hematological Malignancies in the Twilight of the Chemotherapy Era.
Cells
; 10(6)2021 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34203935
20.
Inhibition of PIM Kinases in DLBCL Targets MYC Transcriptional Program and Augments the Efficacy of Anti-CD20 Antibodies.
Cancer Res
; 81(23): 6029-6043, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34625423